Humira vs Tremfya
Adalimumab vs Guselkumab · Comparison Guide
Quick Comparison
| Feature | Humira | Tremfya |
|---|---|---|
| Generic Name | Adalimumab | Guselkumab |
| Manufacturer | AbbVie | Janssen |
| Drug Class | TNF-alpha Inhibitor | IL-23 Inhibitor |
| Shared Conditions | Plaque Psoriasis, Psoriatic Arthritis | |
Key Differences: Humira vs Tremfya
For psoriasis, Tremfya (IL-23 inhibitor) generally demonstrates higher skin clearance rates than Humira (TNF inhibitor). Humira covers many more conditions (RA, Crohn's, UC, AS, HS, uveitis) while Tremfya is approved only for psoriasis and PsA. Tremfya requires only 6–7 injections per year vs 26 for Humira. The VOYAGE 1 and 2 trials showed Tremfya superior to Humira for PASI 90 response at week 24.
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
💊 Tremfya (Guselkumab)
- Class: IL-23 Inhibitor
- Manufacturer: Janssen
- Full Tremfya information →
For psoriasis, Tremfya (IL-23 inhibitor) generally demonstrates higher skin clearance rates than Humira (TNF inhibitor). Humira covers many more conditions (RA, Crohn's, UC, AS, HS, uveitis) while Tremfya is approved only for psoriasis and PsA. Tremfya requires only 6–7 injections per year vs 26 for Humira. The VOYAGE 1 and 2 trials showed Tremfya superior to Humira for PASI 90 response at week 24.
Neither Humira nor Tremfya is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Humira and Tremfya are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Humira and Tremfya both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Humira and Tremfya
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Humira and Tremfya should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.